ATE462710T1 - Mutationen in nod2 sind bei patienten mit morbus crohn mit fibrostenosebildung assoziiert - Google Patents
Mutationen in nod2 sind bei patienten mit morbus crohn mit fibrostenosebildung assoziiertInfo
- Publication number
- ATE462710T1 ATE462710T1 AT03791618T AT03791618T ATE462710T1 AT E462710 T1 ATE462710 T1 AT E462710T1 AT 03791618 T AT03791618 T AT 03791618T AT 03791618 T AT03791618 T AT 03791618T AT E462710 T1 ATE462710 T1 AT E462710T1
- Authority
- AT
- Austria
- Prior art keywords
- disease
- crohn
- fibrostenosis
- fibrostenosing
- nod2
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40739102P | 2002-08-30 | 2002-08-30 | |
US10/356,736 US20040053263A1 (en) | 2002-08-30 | 2003-01-30 | Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease |
PCT/US2003/023926 WO2004020968A2 (en) | 2002-08-30 | 2003-07-30 | Mutations in nod2 are associated with fibrostenosing disease in patients with crohn’s disease |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE462710T1 true ATE462710T1 (de) | 2010-04-15 |
Family
ID=31981139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03791618T ATE462710T1 (de) | 2002-08-30 | 2003-07-30 | Mutationen in nod2 sind bei patienten mit morbus crohn mit fibrostenosebildung assoziiert |
Country Status (7)
Country | Link |
---|---|
US (2) | US20040053263A1 (de) |
EP (1) | EP1556405B1 (de) |
JP (2) | JP4606877B2 (de) |
AT (1) | ATE462710T1 (de) |
AU (1) | AU2003263834A1 (de) |
DE (1) | DE60331941D1 (de) |
WO (1) | WO2004020968A2 (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6828132B2 (en) * | 2001-03-01 | 2004-12-07 | Ultra Biotech Limited | Biological fertilizer compositions comprising garbage |
US20040053263A1 (en) * | 2002-08-30 | 2004-03-18 | Abreu Maria T. | Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease |
US7662569B2 (en) * | 2003-04-11 | 2010-02-16 | Cedars-Sinai Medical Center | Methods of assessing Crohn's disease patient phenotype by I2 serologic response |
US20060205022A1 (en) * | 2003-12-03 | 2006-09-14 | Nir Dotan | Method for diagnosing and prognosing inflammatory bowel disease and crohn's disease |
AU2004294526A1 (en) * | 2003-12-03 | 2005-06-16 | Glycominds, Ltd | Method for diagnosing diseases based on levels of anti-glycan antibodies |
US7592150B2 (en) * | 2003-12-03 | 2009-09-22 | Glycominds, Ltd | Method for diagnosing diseases based on levels of anti-glycan antibodies |
PL1730315T3 (pl) * | 2004-03-27 | 2010-03-31 | Klein Hanns Georg | Polimorfizmy w genie NOD2/CARD15 |
WO2005115135A2 (en) * | 2004-04-09 | 2005-12-08 | The Regents Of The University Of California | Mouse model of crohn’s disease and a method to develop specific therapeutics |
WO2008101133A2 (en) * | 2007-02-14 | 2008-08-21 | Cedars-Sinai Medical Center | Methods of using genes and genetic variants to predict or diagnose inflammatory bowel disease |
US10544459B2 (en) * | 2004-12-08 | 2020-01-28 | Cedars-Sinai Medical Center | Methods of using genetic variants for the diagnosis and treatment of inflammatory bowel disease |
WO2008109782A2 (en) * | 2007-03-06 | 2008-09-12 | Cedars-Sinai Medical Center | Diagnosis of inflammatory bowel disease in children |
US11268149B2 (en) | 2004-12-08 | 2022-03-08 | Cedars-Sinai Medical Center | Diagnosis and treatment of inflammatory bowel disease |
US20100021455A1 (en) * | 2004-12-08 | 2010-01-28 | Cedars-Sinai Medical Center | Methods for diagnosis and treatment of crohn's disease |
WO2008014400A2 (en) * | 2006-07-26 | 2008-01-31 | Genizon Biosciences Inc. | Crohn disease susceptibility gene |
US20080131887A1 (en) | 2006-11-30 | 2008-06-05 | Stephan Dietrich A | Genetic Analysis Systems and Methods |
CA2671267A1 (en) * | 2006-11-30 | 2008-06-05 | Navigenics Inc. | Genetic analysis systems and methods |
WO2008106451A2 (en) * | 2007-02-26 | 2008-09-04 | Cedars-Sinai Medical Center | Methods of using single nucleotide polymorphisms in the tl1a gene to predict or diagnose inflammatory bowel disease |
WO2008116150A2 (en) | 2007-03-21 | 2008-09-25 | Cedars-Sinai Medical Center | Ileal pouch-anal anastomosis (ipaa) factors in the treatment of inflammatory bowel disease |
WO2008134569A2 (en) * | 2007-04-26 | 2008-11-06 | Cedars-Sinai Medical Center | Diagnosis and treatment of inflammatory bowel disease in the puerto rican population |
US20100144903A1 (en) * | 2007-05-04 | 2010-06-10 | Cedars-Sinai Medical Center | Methods of diagnosis and treatment of crohn's disease |
WO2009069007A2 (en) * | 2007-11-30 | 2009-06-04 | Glycominds, Ltd. | Composition and method for prediction of complicated disease course and surgeries in crohn's disease |
WO2009143278A2 (en) * | 2008-05-20 | 2009-11-26 | Cedars-Sinai Medical Center | Methods of diagnosing and characterizing cannabinoid signaling in crohn's disease |
US20110177969A1 (en) * | 2008-10-01 | 2011-07-21 | Cedars-Sinai Medical Center | The role of il17rd and the il23-1l17 pathway in crohn's disease |
US20110189685A1 (en) * | 2008-10-22 | 2011-08-04 | Cedars-Sinai Medical Center | Methods of using jak3 genetic variants to diagnose and predict crohn's disease |
WO2010062960A2 (en) | 2008-11-26 | 2010-06-03 | Cedars-Sinai Medical Center | METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE |
US9580752B2 (en) | 2008-12-24 | 2017-02-28 | Cedars-Sinai Medical Center | Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy |
AU2010236568B2 (en) | 2009-04-14 | 2015-08-27 | Société des Produits Nestlé S.A. | Inflammatory bowel disease prognostics |
WO2011060098A1 (en) | 2009-11-10 | 2011-05-19 | Prometheus Laboratories Inc. | Methods for predicting post-surgery risk associated with ileal pouch-anal anastomosis |
WO2011088306A1 (en) * | 2010-01-15 | 2011-07-21 | Cedars-Sinai Medical Center | Methods of using genetic variants to diagnose crohn's disease |
EP2630495B1 (de) | 2010-10-18 | 2017-02-08 | Nestec S.A. | Verfahren zur bestimmung von gegen medikamente gerichtete antikörperisotypen |
KR20140008397A (ko) | 2011-02-17 | 2014-01-21 | 네스텍 소시에테아노님 | 항-TNFα 약물에 대한 자가항체 검출을 위한 검정법 |
US20140018447A1 (en) * | 2011-03-25 | 2014-01-16 | Cedars-Sinai Medical Center | Methods of diagnosing and treating intestinal granulomas and low bone density in inflammatory bowel disease |
MX362132B (es) | 2011-05-10 | 2019-01-07 | Nestec Sa | Metodos para perfilado de actividad de enfermedad para manejo de terapia personalizado. |
SG11201401536QA (en) | 2011-10-21 | 2014-05-29 | Nestec Sa | Methods for improving inflammatory bowel disease diagnosis |
CA2908553A1 (en) | 2013-03-27 | 2014-10-02 | Cedars-Sinai Medical Center | Mitigation and reversal of fibrosis and inflammation by inhibition of tl1a function and related signaling pathways |
EP2981617B1 (de) | 2013-04-04 | 2023-07-05 | President and Fellows of Harvard College | Therapeutische verwendungen einer genomänderung mit crispr-/cas-systemen |
WO2015010108A1 (en) | 2013-07-19 | 2015-01-22 | Cedars-Sinai Medical Center | Signature of tl1a (tnfsf15) signaling pathway |
US20160348073A1 (en) | 2015-03-27 | 2016-12-01 | President And Fellows Of Harvard College | Modified t cells and methods of making and using the same |
KR20180127416A (ko) | 2016-03-17 | 2018-11-28 | 세다르스-신나이 메디칼 센터 | Rnaset2를 통한 염증성 장 질환의 진단 방법 |
WO2018195129A1 (en) | 2017-04-17 | 2018-10-25 | University Of Maryland, College Park | Embryonic cell cultures and methods of using the same |
WO2020139748A1 (en) * | 2018-12-28 | 2020-07-02 | Cedars-Sinai Medical Center | Methods of treating inflammatory bowel diseases that target ripk2 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3157053B2 (ja) * | 1992-09-16 | 2001-04-16 | ティーディーケイ株式会社 | Dna作用物質の結合様式特定方法 |
ATE193601T1 (de) * | 1993-03-10 | 2000-06-15 | Cedars Sinai Medical Center | Verfahren zum selektiven nachweis von perinuklearen anti-neutrophilen cytoplasmischen antikörpern bei ulzerativen kolitis oder primärer sclerotischer cholangitis |
US5830675A (en) * | 1993-03-10 | 1998-11-03 | Cedars-Sinai Medical Center | Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis, primary sclerosing cholangitis, or type 1 autoimmune hepatitis |
US5691151A (en) * | 1994-10-07 | 1997-11-25 | Regents Of University Of California | Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca |
WO1997038642A1 (en) * | 1996-04-12 | 1997-10-23 | Cedars-Sinai Medical Center | Methods of determining the risk of pouchitis development |
US6074835A (en) * | 1996-04-12 | 2000-06-13 | Regents Of The Univ. Of California | Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using histone H1 |
US5874233A (en) * | 1996-04-12 | 1999-02-23 | Cedars-Sinai Medical Center | Methods of diagnosing a clinical subtype of Crohn's disease with features of ulcerative colitis |
US5916748A (en) * | 1996-04-12 | 1999-06-29 | Cedars-Sinai Medical Center | Method of diagnosing a clinical subtype of crohn's disease with features of ulcerative colitis |
US5968741A (en) * | 1997-04-11 | 1999-10-19 | Cedars-Sinai Medical Center | Methods of diagnosing a medically resistant clinical subtype of ulcerative colitis |
US6514700B1 (en) * | 1999-04-30 | 2003-02-04 | Aclara Biosciences, Inc. | Nucleic acid detection using degradation of a tagged sequence |
JP2001269196A (ja) * | 2000-03-24 | 2001-10-02 | Hamamatsu Photonics Kk | 被検体核酸の定量方法、および被検体核酸の分子数の計数方法 |
US7138237B1 (en) * | 2000-05-19 | 2006-11-21 | Cedars-Sinai Medical Center | Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen |
US20030092019A1 (en) * | 2001-01-09 | 2003-05-15 | Millennium Pharmaceuticals, Inc. | Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia |
US20040053263A1 (en) | 2002-08-30 | 2004-03-18 | Abreu Maria T. | Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease |
-
2003
- 2003-01-30 US US10/356,736 patent/US20040053263A1/en not_active Abandoned
- 2003-07-30 AU AU2003263834A patent/AU2003263834A1/en not_active Abandoned
- 2003-07-30 EP EP03791618A patent/EP1556405B1/de not_active Expired - Lifetime
- 2003-07-30 JP JP2004532837A patent/JP4606877B2/ja not_active Expired - Fee Related
- 2003-07-30 US US10/526,256 patent/US7790370B2/en active Active
- 2003-07-30 DE DE60331941T patent/DE60331941D1/de not_active Expired - Lifetime
- 2003-07-30 WO PCT/US2003/023926 patent/WO2004020968A2/en active Application Filing
- 2003-07-30 AT AT03791618T patent/ATE462710T1/de not_active IP Right Cessation
-
2010
- 2010-08-02 JP JP2010174021A patent/JP2011015686A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2004020968A2 (en) | 2004-03-11 |
JP2006500016A (ja) | 2006-01-05 |
JP4606877B2 (ja) | 2011-01-05 |
US20040053263A1 (en) | 2004-03-18 |
EP1556405A2 (de) | 2005-07-27 |
AU2003263834A8 (en) | 2004-03-19 |
AU2003263834A1 (en) | 2004-03-19 |
EP1556405B1 (de) | 2010-03-31 |
DE60331941D1 (de) | 2010-05-12 |
WO2004020968A3 (en) | 2004-08-26 |
JP2011015686A (ja) | 2011-01-27 |
US7790370B2 (en) | 2010-09-07 |
US20070072180A1 (en) | 2007-03-29 |
EP1556405A4 (de) | 2007-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE462710T1 (de) | Mutationen in nod2 sind bei patienten mit morbus crohn mit fibrostenosebildung assoziiert | |
WO2008137762A3 (en) | Methods of diagnosis and treatment of crohn's disease | |
WO2005020784A3 (en) | Surrogate cell gene expression signatures for evaluating the physical state of a subject | |
CA2282746A1 (en) | Prediction of coronary artery disease | |
DE69941214D1 (de) | DIAGNOSE, VORBEUGUNG UND BEHANDLUNG VON ULCERATIVER COLITIS UND DEREN SUBTYPEN UNTER VERWENDUNG MIKROBIELLER UC pANCA ANTIGENE | |
Stone et al. | Selection of acute stroke patients for treatment of visual neglect. | |
DE69231595D1 (de) | Bestimmung von mutationen im zusammenhang mit dem digeorge-syndrom | |
WO2000018954A3 (en) | Use of pex in the treatment of metabolic bone diseases | |
Aaltonen et al. | Motives for physical activity in older men and women: A twin study using accelerometer‐measured physical activity | |
Verthein et al. | Significance of comorbidity for the long-term course of opiate dependence | |
WO2006113880A3 (en) | Intact igfbp-3 as a colon cancer risk factor in patients with inflammatory bowel disease | |
SE0300959D0 (sv) | Methods for predicting therapeutic response to agents acting on the growth hormone receptor | |
AU4753900A (en) | Methods of diagnosing or treating alzheimer's disease | |
WO2001004343A3 (en) | A method for determining the prognosis of cancer patients by measuring levels of bag expression | |
ATE449964T1 (de) | DIAGNOSTISCHE VERWENDUNG VON ßENSADIN-0477ß FÜR NEURODEGENERATIVE ERKRANKUNGEN | |
Hurko et al. | Neurology and the skin | |
AU2003233292A8 (en) | Protein c polymorphisms | |
DE60229513D1 (de) | Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten | |
Hughes et al. | Diagnosis and management of smouldering myeloma: a British Society for Haematology Good Practice Paper | |
EP1722225A4 (de) | Verfahren zur diagnose der immunität wiederkehrenden spontanen schwangerschaftsabbruchs sowie verfahren zur behandlung und überwachung | |
GB0223655D0 (en) | Method of diagnosis | |
Yang et al. | A novel methionine-53-valine mutation of p16 in a hereditary melanoma kindred | |
WO2003007801A3 (en) | Diagnosis and treatment of vascular disease | |
DE60329224D1 (de) | Verfahren zur Bestimmung von zirkulierender DNS in Plasma und zum Nachweis von Krebs | |
Ibrahim et al. | Could Ambulatory Blood Pressure Monitoring Be a Routine Investigation for Patients with Mild Cognitive Impairment? |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |